{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:26:20Z","timestamp":1792801580399,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Paraquat, still used as an herbicide in some parts of the world, is now regarded as a dangerous environmental neurotoxin and is linked to the development Parkinson\u2019s disease (PD). Paraquat interacts with cellular redox systems and causes mitochondrial dysfunction and the formation of reactive oxygen species, which in turn, plays a crucial role in the pathophysiology of PD. Various antioxidant therapies have been explored with the expectations that they deliver health benefits to the PD patients, however, no such therapies were effective. Here we have tested the neuroprotective efficacy of a novel water-soluble CoQ<jats:sub>10<\/jats:sub> (Ubisol-Q<jats:sub>10<\/jats:sub>), in a rat model of paraquat-induced neurodegeneration in order to evaluate its potential application in the management of PD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We have developed a rat model of progressive nigrostriatal degeneration by giving rats five intraperitoneal injections of paraquat (10\u00a0mg\/kg\/injection), once every five days. Neuronal death occurred over a period of 8\u00a0weeks with close to 50% reduction in the number of tyrosine hydroxylase-positive cells. Ubisol-Q<jats:sub>10<\/jats:sub>, at 6\u00a0mg CoQ<jats:sub>10<\/jats:sub>\/kg body weight\/day, was delivered as a supplement in drinking water. The intervention begun after the completion of paraquat injections when the neurodegenerative process had already began and about 20% of TH-positive neurons were lost. Ubisol-Q<jats:sub>10<\/jats:sub> treatment halted the progression of neurodegeneration and remaining neurons were protected. The outcomes were evaluated based on the number of surviving tyrosine hydroxylase-positive neurons in the substantia nigra region and improved motor skills in response to the Ubisol-Q<jats:sub>10<\/jats:sub> intervention. To maintain this neuroprotection, however, continuous Ubisol- Q<jats:sub>10<\/jats:sub> supplementation was required, if withdrawn, the neuronal death pathway resumed, suggesting that the presence of CoQ<jats:sub>10<\/jats:sub> was essential for blocking the pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The CoQ<jats:sub>10<\/jats:sub>, given orally as Ubisol-Q<jats:sub>10<\/jats:sub> in drinking solution, was effective in blocking the progression of neurodegeneration when administered therapeutically (post-toxin injection), at a much lower concentration than other previously tested oil soluble formulations and well within the acceptable daily intake of 12\u00a0mg\/kg\/day. Such unprecedented neuroprotection has never been reported before. These results are very encouraging and suggest that Ubisol-Q<jats:sub>10<\/jats:sub> should be further tested and developed as a therapy for halting the progression of PD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/1471-2202-15-21","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T20:01:07Z","timestamp":1391198467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Krithika","family":"Muthukumaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Sikorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdeep K","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine","family":"Keshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lopatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Borowy-Borowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lanthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyaram","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,31]]},"reference":[{"issue":"8","key":"3474_CR1","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/archneur.62.8.1265","volume":"62","author":"LM de Lau","year":"2005","unstructured":"de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM: Prognosis of Parkinson Disease Risk of Dementia and Mortality: The Rotterdam Study. Arch Neurol. 2005, 62 (8): 1265-1269. 10.1001\/archneur.62.8.1265.","journal-title":"Arch Neurol"},{"issue":"S3","key":"3474_CR2","doi-asserted-by":"publisher","first-page":"S495","DOI":"10.1002\/mds.22048","volume":"23","author":"CW Olanow","year":"2008","unstructured":"Olanow CW, Lees A, Obeso J: Levodopa therapy for Parkinson\u2019s disease: challenges and future prospects.le first published online. Mov Disord. 2008, 23 (S3): S495-S496. 10.1002\/mds.22048.","journal-title":"Mov Disord"},{"issue":"22","key":"3474_CR3","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1212\/01.wnl.0000271880.27321.a7","volume":"69","author":"C Klein","year":"2007","unstructured":"Klein C, Schlossmacher MG: Parkinson disease, 10\u00a0years after its genetic revolution: multiple clues to a complex disorder. Neurology. 2007, 69 (22): 2093-2104. 10.1212\/01.wnl.0000271880.27321.a7.","journal-title":"Neurology"},{"key":"3474_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/bmb\/ldn013","volume":"86","author":"CA Davie","year":"2008","unstructured":"Davie CA: A review of Parkinson\u2019s disease. Br Med Bull. 2008, 86: 109-127. 10.1093\/bmb\/ldn013.","journal-title":"Br Med Bull"},{"key":"3474_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I: Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983, 219: 979-983. 10.1126\/science.6823561.","journal-title":"Science"},{"issue":"4","key":"3474_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1471-4159.1988.tb10610.x","volume":"50","author":"NJ Riachi","year":"1988","unstructured":"Riachi NJ, Arora PK, Sayre LM, Harik SI: Potent Neurotoxic Fluorinated 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Analogs as Potential Probes in Models of Parkinson Disease. J Neurochem. 1988, 50 (4): 1319-1321. 10.1111\/j.1471-4159.1988.tb10610.x.","journal-title":"J Neurochem"},{"key":"3474_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0006-8993(87)90986-3","volume":"405","author":"ME Sundstorm","year":"1987","unstructured":"Sundstorm ME, Stromberg I, Tsutsumi T, Olson L, Jonsson G: Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL\/6 mice. Comparison with three other strains of mice. Brain Res. 1987, 405: 26-38. 10.1016\/0006-8993(87)90986-3.","journal-title":"Brain Res"},{"issue":"Suppl","key":"3474_CR8","doi-asserted-by":"publisher","first-page":"299S","DOI":"10.1016\/0197-0186(92)90256-Q","volume":"20","author":"RE Heikkila","year":"1992","unstructured":"Heikkila RE, Sonsalla PK: The MPTP-treated mouse as a model of Parkinsonism: how good is it?. Neurochem Int. 1992, 20 (Suppl): 299S-303S.","journal-title":"Neurochem Int"},{"key":"3474_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2010.01.053","volume":"1341","author":"KM Gerecke","year":"2010","unstructured":"Gerecke KM, Jiao Y, Pani A, Pagala V, Smeyne RJ: Exercise protects against MPTP-induced neurotoxicity in mice. Brain Res. 2010, 1341: 72-83.","journal-title":"Brain Res"},{"key":"3474_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cdd.2009.217","volume":"17","author":"C Berry","year":"2010","unstructured":"Berry C, la Vecchia C, Nicotera P: Paraquat and Parkinson\u2019s disease. Cell Death Differ. 2010, 17: 1115-1125. 10.1038\/cdd.2009.217.","journal-title":"Cell Death Differ"},{"issue":"51","key":"3474_CR11","doi-asserted-by":"publisher","first-page":"20766","DOI":"10.1073\/pnas.1115141108","volume":"108","author":"P Rappold","year":"2011","unstructured":"Rappold P, Cui M, Chesser AS, Tibbett J, Grima JC, Duan L, Sen N, Javitch JA, Tieu K: Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proc Natl Acad Sci USA. 2011, 108 (51): 20766-20771. 10.1073\/pnas.1115141108.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3474_CR12","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","volume":"48","author":"HH Liou","year":"1997","unstructured":"Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC: Environmental risk factors and Parkinson\u2019s disease: a case\u2013control study in Taiwan. Neurology. 1997, 48 (6): 1583-1588. 10.1212\/WNL.48.6.1583.","journal-title":"Neurology"},{"issue":"12","key":"3474_CR13","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1289\/ehp.0900852","volume":"117","author":"NM Gatto","year":"2009","unstructured":"Gatto NM, Cockburn M, Bronstein J, Manthripragada AD, Ritz M: Well-water consumption and Parkinson\u2019s Disease in rural California. Environ Health Perspect. 2009, 117 (12): 1912-1918. 10.1289\/ehp.0900852.","journal-title":"Environ Health Perspect"},{"key":"3474_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2202-10-88","volume":"10","author":"M Somayajulu-Ni\u0163u","year":"2009","unstructured":"Somayajulu-Ni\u0163u M, Sandhu J, Cohen J, Sikorska M, Sridhar T, Matei A, Borowy-Borowski H, Pandey S: Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10. BMC Neurosci. 2009, 10: 88-10.1186\/1471-2202-10-88.","journal-title":"BMC Neurosci"},{"key":"3474_CR15","first-page":"597","volume":"5","author":"M Spindler","year":"2009","unstructured":"Spindler M, Beal MF, Henchcliffe C: Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009, 5: 597-610.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3474_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/10611860412331285233","volume":"12","author":"H Borowy-Borowski","year":"2004","unstructured":"Borowy-Borowski H, Sodja C, Docherty J, Walker PR, Sikorska M: Unique technology for solubilization and delivery of highly lipophilic bioactive molecules. J Drug Target. 2004, 12: 415-424. 10.1080\/10611860412331285233.","journal-title":"J Drug Target"},{"issue":"1\u20134","key":"3474_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/biof.5520180220","volume":"18","author":"M Sikorska","year":"2003","unstructured":"Sikorska M, Borowy-Borowski H, Zurakowski B, Walker PR: Derivatised alpha-tocopherol as a CoQ10 carrier in a novel water-soluble formulation. Biofactors. 2003, 18 (1\u20134): 173-183.","journal-title":"Biofactors"},{"key":"3474_CR18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.nbd.2004.10.021","volume":"18","author":"M Somayajulu","year":"2005","unstructured":"Somayajulu M, McCarthy S, Hung M, Sikorska M, Borowy-Borowski H, Pandey S: Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10. Neurobiol Dis. 2005, 18: 618-625. 10.1016\/j.nbd.2004.10.021.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"3474_CR19","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","volume":"104","author":"C Cleren","year":"2008","unstructured":"Cleren C, Yang L, Lorenzo B, Calingasan NY, Schomer A, Sireci A, Wille EJ, Beal MF: Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem. 2008, 104 (6): 1613-1621. 10.1111\/j.1471-4159.2007.05097.x.","journal-title":"J Neurochem"},{"issue":"1","key":"3474_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1590\/S0102-67202012000100011","volume":"25","author":"N Andrello","year":"2012","unstructured":"Andrello N, Santos E, Araujo M, Lopes L: Rat\u2019s age versus human\u2019s age: what\u2019s the relationship?. Arq Bras Cir Dig. 2012, 25 (1): 49-51. 10.1590\/S0102-67202012000100011.","journal-title":"Arq Bras Cir Dig"},{"issue":"9","key":"3474_CR21","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2004","unstructured":"Fornai F, Schl\u00fcter OM, Lenzi , Gesi M, Ruffoli R, Ferrucci F, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, S\u00fcdhof TC: Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and \u03b1-synuclein. Proc Natl Acad Sci USA. 2004, 102 (9): 3413-3418.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3474_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW: Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect. 2011, 119 (6): 866-872. 10.1289\/ehp.1002839.","journal-title":"Environ Health Perspect"},{"issue":"2","key":"3474_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2005.03.018","volume":"20","author":"F Cicchetti","year":"2005","unstructured":"Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE: Systemic exposure to paraquat and maneb models early Parkinson\u2019s disease in young adult rats. Neurobiol Dis. 2005, 20 (2): 360-371. 10.1016\/j.nbd.2005.03.018.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"3474_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10495-006-8417-4","volume":"11","author":"J Naderi","year":"2006","unstructured":"Naderi J, Somayajulu-Nitu M, Mukerji A, Sharda P, Sikorska M, Borowy-Borowski H, Antonsson B, Pandey S: Water-soluble formulation of Coenzyme Q10 inhibits Bax-induced destabilization of mitochondria in mammalian cells. Apoptosis. 2006, 11 (8): 1359-1369. 10.1007\/s10495-006-8417-4.","journal-title":"Apoptosis"},{"issue":"5","key":"3474_CR25","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","volume":"109","author":"L Yang","year":"2009","unstructured":"Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF: Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases. J Neurochem. 2009, 109 (5): 1427-1439. 10.1111\/j.1471-4159.2009.06074.x.","journal-title":"J Neurochem"},{"issue":"12","key":"3474_CR26","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1177\/0091270007307571","volume":"47","author":"R Constantinescu","year":"2007","unstructured":"Constantinescu R, McDermott MP, Dicenzo R, de Blieck EA, Hyson HC, Beal MF, Bednarczyk EM, Bogdanov M, Metakis LJ, Browne SE, Lorenzo BJ, Ravina B, Kieburtz K: A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone). J Clin Pharmacol. 2007, 47 (12): 1580-1586. 10.1177\/0091270007307571.","journal-title":"J Clin Pharmacol"},{"key":"3474_CR27","first-page":"353","volume":"108","author":"S Graves","year":"1998","unstructured":"Graves S, Sikorska M, Borowy-Borowski H, Ho RJ, Bui T, Woodhouse C: Analysis of coenzyme Q10 content in human plasma and other biological samples. Methods Mol Biol. 1998, 108: 353-365.","journal-title":"Methods Mol Biol"},{"issue":"1\u20132","key":"3474_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cccn.2003.12.002","volume":"341","author":"PH Tang","year":"2004","unstructured":"Tang PH, Miles MV, Miles L, Quinlan J, Wong B, Wenisch A, Bove K: Measurement of reduced and oxidized coenzyme Q9 and coenzyme Q10 levels in mouse tissues by HPLC with coulometric detection. Clin Chim Acta. 2004, 341 (1\u20132): 173-184.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"3474_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.cbpb.2007.02.001","volume":"147","author":"N Souchet","year":"2007","unstructured":"Souchet N, Laplante S: Seasonal and geographical variations of sterol composition in snow crab hepatopancreas and pelagic fish viscera from Eastern Quebec. Comp Biochem Physiol B Biochem Mol Biol. 2007, 147 (3): 378-386. 10.1016\/j.cbpb.2007.02.001.","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"52","key":"3474_CR30","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.1073\/pnas.0405831102","volume":"101","author":"N Maswood","year":"2004","unstructured":"Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, Gerhardt GA, Grondin R, Roth GS, Mattison J, Lane MA, Carson RE, Cohen RM, Mouton PR, Quigley C, Mattson MP, Ingram K: Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in aprimate model of Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2004, 101 (52): 18171-18176. 10.1073\/pnas.0405831102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"3474_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0165-0270(98)00100-9","volume":"84","author":"JM Long","year":"1998","unstructured":"Long JM, Kalehua AN, Muth NJ, Hengemihle JM, Jucker M, Calhoun ME, Ingram DK, Mouton PR: Stereological estimation of total microglia number in mouse hippocampus. J Neurosci Methods. 1998, 84 (1\u20132): 101-108.","journal-title":"J Neurosci Methods"}],"updated-by":[{"DOI":"10.1186\/s12868-021-00684-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000}}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-15-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T10:12:30Z","timestamp":1639995150000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-15-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,31]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3474"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-15-21","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,31]]},"assertion":[{"value":"28 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12868-021-00684-7","URL":"https:\/\/doi.org\/10.1186\/s12868-021-00684-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"21"}}